Warby Parker Inc.

WRBY

Warby Parker Inc.

WRBY

Insider Sentiment (TTM):

Last Purchase:2024-08-14Last Sale:2026-06-16Shares Purchased (TTM):0Shares Sold (TTM):1,245,432

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:95,403,753Shares Outstanding:123,438,000Institutional Ownership Pct.:77.29%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Ophthalmic Goods

COO BLCO EYE STAA RXST LUCY

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Common Class A And B	-	0	-	-	-	0	-	-	-	0	-	-
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	288	286	280	286	265	254	251	238	220	217	216	213
Accounts Receivable Net Current	2	3	1	1	1	2	1	1	1	2	1	1
Inventory Net	46	45	46	43	49	52	53	53	56	62	64	60
Prepaid Expense And Other Assets Current	21	18	17	15	15	18	16	16	18	18	15	14
Assets Current	358	352	344	346	331	326	321	309	296	299	295	288
Property Plant And Equipment Net	191	187	183	177	174	170	167	163	157	152	151	144
Operating Lease Right Of Use Asset	175	171	172	170	170	171	142	138	130	122	120	122
Other Assets Noncurrent	12	10	9	8	8	9	9	9	10	7	8	8
Assets	736	721	707	702	683	676	638	618	593	580	575	562
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	37	32	11	26	27	24	37	25	27	22	24	24
Accrued Liabilities Current	60	49	68	61	52	52	46	48	43	46	55	43
Contract With Customer Liability Current	21	34	22	22	23	32	19	21	21	32	18	19
Operating Lease Liability Current	32	31	29	25	19	20	26	26	24	24	23	23
Other Liabilities Current	3	4	3	3	3	3	2	2	3	2	2	2
Liabilities Current	153	150	132	136	123	130	130	121	119	127	122	110
Operating Lease Liability Noncurrent	206	202	204	204	205	205	170	167	157	150	147	148
Other Liabilities Noncurrent	2	1	1	1	1	1	1	1	1	1	1	1
Liabilities	361	353	337	340	329	336	301	289	277	279	270	260
Stockholders Equity Inclu…
Common Stock Value	0	-	0	0	0	-	0	0	0	-	0	0
Additional Paid In Capital	1,060	1,055	1,051	1,049	1,040	1,029	1,019	1,007	987	970	954	934
Retained Earnings Accumulated Deficit	-682	-686	-680	-686	-684	-687	-680	-676	-670	-667	-648	-630
Accumulated Other Comprehensive Income Loss Net Of…	-2	-1	-2	-2	-2	-2	-2	-2	-2	-2	-2	-1
Stockholders Equity	376	368	370	361	354	340	337	329	316	302	305	302
Liabilities And Stockholders Equity	736	721	707	702	683	676	638	618	593	580	575	562
Common Class A	107	750	-644	0	750	103	0	0	750	98	-	0
Common Class B	16	150	-134	0	150	18	0	0	150	20	-	0
Temporary Equity Shares Outstanding	-	-	-	-	-	-	-	-	-	0	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	1,050	1,050	1,050	1,050	1,050	1,050	1,050	1,050	1,050	1,050	1,050	1,050

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-9.85%	7.50%	-9.71%	-	-	-	-	-	-	-	-	-
2025	27.38%	31.71%	46.75%	12.30%	18.30%	-8.87%	17.01%	42.82%	55.82%	-11.54%	-3.08%	12.01%
2024	20.64%	9.40%	12.53%	6.27%	14.17%	21.94%	16.73%	26.46%	34.59%	-22.25%	-41.34%	-27.15%
2023	0.66%	-3.63%	21.02%	-12.60%	-5.26%	-7.27%	1.66%	29.71%	19.32%	0.31%	-5.19%	30.06%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.33	2.35	2.61	2.55	2.70	2.50	2.47	2.55	2.50	2.35	2.43	2.61
Quick Ratio	1.89	1.93	2.13	2.12	2.17	1.96	1.94	1.98	1.87	1.72	1.78	1.94
Working Capital	204.41M	202.31M	211.99M	210.56M	207.98M	195.69M	191.09M	187.60M	177.58M	171.53M	173.67M	177.61M
Leverage & Debt
Debt to Equity	0.96	0.96	0.91	0.94	0.93	0.99	0.89	0.88	0.88	0.92	0.89	0.86
Debt Ratio	0.49	0.49	0.48	0.49	0.48	0.50	0.47	0.47	0.47	0.48	0.47	0.46
Efficiency & Turnover
Asset Turnover TTM	1.26	1.25	1.26	1.24	1.25	1.23	1.22	1.22	1.21	1.17	1.16	1.15
Days Sales Outstanding TTM	0.66	1.10	0.48	0.52	0.61	0.88	0.45	0.60	0.56	0.88	0.51	0.60
Receivables Turnover TTM	550.75	333.23	760.46	699.61	602.34	413.91	818.21	603.46	655.52	416.78	715.19	609.56
Per Share Metrics
Diluted EPS TTM	0.01	0.01	0.01	-0.08	-0.11	-0.17	-0.27	-0.38	-0.46	-0.54	-0.55	-0.61
Free Cash Flow Per Share TTM	0.32	0.36	0.31	0.43	0.35	0.29	0.27	0.20	0.14	0.06	0.14	-0.00
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	53.41%	53.97%	54.39%	54.49%	55.26%	55.34%	55.32%	55.37%	55.01%	54.53%	54.83%	55.34%
Operating Profit Margin TTM	-0.69%	-0.61%	-0.93%	-2.20%	-2.83%	-3.90%	-5.69%	-7.70%	-9.27%	-10.75%	-11.02%	-12.01%
Net Profit Margin TTM	0.15%	0.19%	0.08%	-1.12%	-1.79%	-2.64%	-4.39%	-6.38%	-7.89%	-9.44%	-9.84%	-11.18%
Growth Metrics
Net Revenue Growth (1Y)	12.01%	13.04%	14.55%	14.09%	13.94%	15.16%	13.47%	13.67%	13.12%	11.98%	-23.47%	-24.93%
Net Income Growth (1Y)	-109.45%	-108.05%	-102.20%	-79.89%	-74.14%	-67.74%	-49.44%	-35.20%	-36.76%	-42.75%	-58.84%	-68.34%
EPS Growth (1Y)	-109.34%	-107.90%	-102.16%	-80.30%	-74.74%	-68.54%	-50.65%	-36.97%	-38.34%	-43.95%	-59.80%	-68.91%
Valuation Metrics
P/E TTM	1,932.27	1,628.87	4,729.87	-291.24	-156.13	-142.94	-60.63	-42.02	-29.45	-26.19	-24.11	-19.28
P/B TTM	6.92	7.27	9.18	7.44	6.28	8.57	5.86	5.86	5.13	5.48	5.10	4.52
P/S TTM	2.92	3.07	3.99	3.27	2.80	3.78	2.66	2.68	2.32	2.47	2.37	2.16
Market Cap	2.60B	2.67B	3.39B	2.69B	2.22B	2.91B	1.97B	1.93B	1.62B	1.66B	1.55B	1.37B
Enterprise Value	2.31B	2.39B	3.11B	2.40B	1.96B	2.66B	1.72B	1.69B	1.40B	1.44B	1.34B	1.15B
Calculated Values
Free Cash Flow TTM	38.90M	43.74M	37.79M	52.37M	42.43M	34.71M	32.61M	24.00M	16.55M	7.32M	16.85M	-533.00K
Net Debt	-288.25M	-286.36M	-280.36M	-286.38M	-265.07M	-254.16M	-251.03M	-237.96M	-220.38M	-216.89M	-215.97M	-212.66M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-16Sale

Owner: Briggs, Teresa

Title: -

Shares: 5,000

Price/Share: $26.10

Value: $130,500.00

Shares Owned: 48,883

Relationship: Director

Ownership: Direct

2026-06-12Sale

Owner: Moon, Youngme E

Title: -

Shares: 10,000

Price/Share: $26.53

Value: $265,300.00

Shares Owned: 26,061

Relationship: Director

Ownership: Direct

2026-05-19Sale

Owner: Blumenthal, Neil Harris

Title: Co-Chief Executive Officer

Shares: 63,040

Price/Share: $30.03

Value: $1,893,091.20

Shares Owned: 50,165

Relationship: Director,Officer

Ownership: Direct

2026-05-14Sale

Owner: Singer, Bradley E

Title: -

Shares: 4,833

Price/Share: $29.01

Value: $140,205.33

Shares Owned: 100,000

Relationship: Director

Ownership: Indirect

2026-04-20Sale

Owner: Blumenthal, Neil Harris

Title: Co-Chief Executive Officer

Shares: 22,442

Price/Share: $25.09

Value: $563,069.78

Shares Owned: 50,165

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-16	Briggs, Teresa	Director	-	Direct	Sale	5,000	26.10	$130,500.00	48,883	4
2026-06-12	Moon, Youngme E	Director	-	Direct	Sale	10,000	26.53	$265,300.00	26,061	4
2026-05-19	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	63,040	30.03	$1,893,091.20	50,165	4
2026-05-14	Singer, Bradley E	Director	-	Indirect	Sale	4,833	29.01	$140,205.33	100,000	4
2026-04-20	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	22,442	25.09	$563,069.78	50,165	4
2026-03-11	Raider, Jeffrey Jacob	Director	-	Direct	Sale	25,000	25.43	$635,750.00	448,697	4
2026-03-04	Singer, Bradley E	Director	-	Direct	Sale	15,793	27.53	$434,781.29	16,026	4
2026-01-13	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	660	29.99	$19,793.40	37,119	4
2026-01-13	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	80,094	29.46	$2,359,569.24	37,247	4
2026-01-09	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	19,906	29.09	$579,065.54	37,247	4
2026-01-07	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	50,000	27.08	$1,354,000.00	37,119	4
2026-01-06	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	150,000	25.09	$3,763,500.00	37,119	4
2026-01-06	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	50,000	24.29	$1,214,500.00	37,247	4
2025-12-16	Cutler, Joel E	Director	-	Indirect	Sale	19,932	26.01	$518,431.32	20,000	4
2025-12-12	Raider, Jeffrey Jacob	Director	-	Direct	Sale	25,000	27.42	$685,500.00	483,485	4
2025-12-11	Moon, Youngme E	Director	-	Direct	Sale	38,832	29.07	$1,128,846.24	27,057	4
2025-12-11	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	200,000	30.20	$6,040,000.00	37,247	4
2025-12-11	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	100,000	30.29	$3,029,000.00	37,119	4
2025-10-01	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	125,000	27.30	$3,412,500.00	32,861	4
2025-09-18	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	58,360	27.58	$1,609,568.80	32,861	4
2025-09-18	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	8,416	27.52	$231,608.32	32,733	4
2025-09-11	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	41,084	27.53	$1,131,042.52	32,733	4
2025-09-11	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	41,040	27.53	$1,129,831.20	32,861	4
2025-09-08	Cutler, Joel E	Director	-	Indirect	Sale	35,000	26.75	$936,250.00	19,932	4
2025-08-13	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	50,000	25.11	$1,255,500.00	28,347	4
2025-08-11	Briggs, Teresa	Director	-	Direct	Sale	6,000	23.56	$141,360.00	44,879	4
2025-07-21	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	74,500	24.27	$1,808,115.00	28,475	4
2025-07-21	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	49,600	24.21	$1,200,816.00	28,347	4
2025-07-01	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	50,000	22.04	$1,102,000.00	28,475	4
2025-05-22	Moon, Youngme E	Director	-	Direct	Sale	33,073	19.90	$658,152.70	53,869	4
2025-03-04	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	202,968	23.65	$4,800,193.20	24,089	4
2025-03-04	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	11,684	23.52	$274,807.68	204,727	4
2025-03-04	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	27,967	23.52	$657,783.84	23,961	4
2025-01-30	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	50,000	27.61	$1,380,500.00	12,177	4
2025-01-03	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	36,996	25.41	$940,068.36	12,306	4
2025-01-02	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	300,000	25.14	$7,542,000.00	12,177	4
2024-12-20	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	144,212	25.11	$3,621,163.32	12,306	4
2024-12-20	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	93,946	25.08	$2,356,165.68	12,177	4
2024-12-18	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	55,788	25.09	$1,399,720.92	12,306	4
2024-12-18	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	56,054	25.09	$1,406,394.86	12,177	4
2024-12-11	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	54,000	23.84	$1,287,360.00	12,306	4
2024-12-11	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	7,016	23.85	$167,331.60	182,130	4
2024-12-09	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	50,000	23.65	$1,182,500.00	12,177	4
2024-12-03	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	14,853	22.61	$335,826.33	189,146	4
2024-12-03	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	36,163	22.61	$817,645.43	12,306	4
2024-12-03	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	36,163	22.61	$817,645.43	12,177	4
2024-09-11	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	6,763	13.90	$94,005.70	177,488	4
2024-09-10	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	49,034	13.69	$671,275.46	12,306	4
2024-09-09	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	50,000	14.02	$701,000.00	12,177	4
2024-09-06	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	15,272	13.00	$198,536.00	184,251	4
2024-08-14	Singer, Bradley E	Director	-	Indirect	Purchase	25,000	12.63	$315,750.00	125,000	4
2024-06-14	D1, Capital Partners L.P.…	TenPercentOwner	-	Indirect	Sale	5,500,000	15.66	$86,130,000.00	9,444,023	4
2024-06-13	Briggs, Teresa	Director	-	Direct	Sale	7,396	16.31	$120,628.76	38,859	4
2024-06-12	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	99,816	16.61	$1,657,943.76	173,012	4
2024-06-10	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	149,034	16.69	$2,487,377.46	12,306	4
2024-06-07	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	69,439	16.59	$1,151,993.01	166,879	4
2024-06-07	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	76,582	16.66	$1,275,856.12	12,177	4
2024-03-11	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	24,225	11.98	$290,215.50	166,879	4
2024-03-08	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	52,065	12.20	$635,193.00	12,306	4
2024-03-07	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	50,000	12.40	$620,000.00	12,177	4
2024-03-06	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	8,708	11.88	$103,451.04	191,104	4
2024-03-05	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	8,963	12.12	$108,631.56	178,653	4
2024-03-05	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	16,731	12.12	$202,779.72	12,177	4
2024-03-05	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	16,731	12.12	$202,779.72	12,306	4
2023-12-14	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	10,875	12.22	$132,892.50	166,879	4
2023-12-11	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	21,550	11.42	$246,101.00	177,754	4
2023-12-08	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Office	Direct	Sale	56,038	10.56	$591,761.28	235	4
2023-12-08	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	56,038	10.56	$591,761.28	106	4
2023-09-08	Miller, Steven Clive	Officer	Chief Financial Officer	Direct	Sale	7,607	11.92	$90,675.44	187,252	4
2023-09-08	Blumenthal, Neil Harris	Director,Officer	Co-Chief Executive Officer	Direct	Sale	5,016	11.92	$59,790.72	106	4
2023-09-08	Gilboa, David Abraham	Director,Officer	Co-Chief Executive Officer	Direct	Sale	5,016	11.92	$59,790.72	235	4
2023-08-21	Durable, Capital Partners…	TenPercentOwner	-	Indirect	Sale	402,535	12.23	$4,923,003.05	9,690,563	4
2023-08-14	Briggs, Teresa	Director	-	Indirect	Sale	9,720	12.95	$125,874.00	13,820	4
2023-06-22	Durable, Capital Partners…	TenPercentOwner	-	Indirect	Sale	24,151	11.91	$287,638.41	10,093,098	4
2023-06-21	Durable, Capital Partners…	TenPercentOwner	-	Indirect	Sale	218,088	11.91	$2,597,428.08	10,117,249	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

77.29%

Inst. Shares: 95,403,753

Shares Outstanding: 123,438,000

2025-12-31

84.86%

Inst. Shares: 104,100,471

Shares Outstanding: 122,670,000

2025-09-30

79.53%

Inst. Shares: 97,793,306

Shares Outstanding: 122,963,000

2025-06-30

78.99%

Inst. Shares: 96,812,186

Shares Outstanding: 122,565,000

2025-03-31

74.06%

Inst. Shares: 90,313,277

Shares Outstanding: 121,946,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	95,403,753	123,438,000	77.29%
2025-12-31	104,100,471	122,670,000	84.86%
2025-09-30	97,793,306	122,963,000	79.53%
2025-06-30	96,812,186	122,565,000	78.99%
2025-03-31	90,313,277	121,946,000	74.06%
2024-12-31	92,409,409	120,385,000	76.76%
2024-09-30	91,735,223	120,886,000	75.89%
2024-06-30	87,802,619	120,086,000	73.12%
2024-03-31	82,605,006	119,144,000	69.33%
2023-12-31	82,926,634	117,389,000	70.64%
2023-09-30	83,870,238	118,003,640	71.07%
2023-06-30	79,945,010	116,792,223	68.45%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Warby Parker Inc. (WRBY) — SEC Financial Statements & Analysis

Warby Parker Inc. (WRBY) is a ophthalmic goods company, incorporated in DE. Warby Parker Inc. trades on NYSE as: WRBY. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Warby Parker Inc. reported a 12.01% year-over-year revenue growth, a Gross Profit Margin of 53.41% (TTM), a Debt-to-Equity ratio of 0.96x, a Price-to-Sales (P/S) ratio of 2.92x (TTM), a Price-to-Book (P/B) ratio of 6.92 (TTM), at a market cap of $2.60B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 12.01%
Gross Profit Margin TTM: 53.41%
Debt To Equity: 0.96x
P/S TTM: 2.92x
P/B TTM: 6.92
Market Cap: $2.60B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Warby Parker Inc. in?

Warby Parker Inc. (WRBY) operates in the Ophthalmic Goods industry.

What is WRBY's market cap?

Warby Parker Inc. (WRBY) has a market capitalization of $2.60B as of 2026-03-31.

What is WRBY's P/E ratio?

Warby Parker Inc. (WRBY)'s trailing twelve month P/E ratio is 1932.27x as of 2026-03-31.

What exchange does WRBY trade on?

Warby Parker Inc. (WRBY) trades on the NYSE.

Where is Warby Parker Inc. incorporated?

Warby Parker Inc. is incorporated in DE.

Warby Parker Inc. (WRBY) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.